Comparative cardiovascular benefits of individual SGLT2 inhibitors in type 2 diabetes and heart failure: a systematic review and network meta-analysis of randomized controlled trials

External Link

https://www.frontiersin.org/journals/endocrinology/articles/10.3389/fendo.2023.1216160/full